| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dd98ad4ee076841fec541542f952f58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-61 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04 |
| filingDate |
2017-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c15e820f22c47c4b73a23447b8b2e695 |
| publicationDate |
2018-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018053517-A1 |
| titleOfInvention |
Inhibitors of ldlr-pcsk9 protein-protein interaction and methods of their use |
| abstract |
Compounds that disrupt the interaction between PCSK9 and LDLR, compositions that include the compounds, and methods for making and using the compounds and compositions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11530244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484565-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11427616-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021041770-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3630434-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11306125-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11505575-B2 |
| priorityDate |
2016-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |